Results 191 to 200 of about 27,592 (211)

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus

Circulation, 2018
Robert P Giugliano, Christopher P Cannon, Jeong-Gun Park   +2 more
exaly  

Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT

Circulation, 2015
Robert P Giugliano, Christopher P Cannon, Jing Zhou   +2 more
exaly  

Use of Ezetimibe in the United States and Canada

New England Journal of Medicine, 2008
Cynthia A Jackevicius, Jack V Tu, Joseph S. Ross   +2 more
exaly  

Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial

Lancet, The, 2022
exaly  

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

Circulation, 2017
Robert P Giugliano, Jeong-Gun Park, Harvey D White   +2 more
exaly  

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

New England Journal of Medicine, 2008
John B Chambers, Eva Gerdts, Christoph A Nienaber   +2 more
exaly  

Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients With Sitosterolemia

Circulation, 2004
Dieter Lütjohann
exaly  

Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial

Lancet, The, 2012
Evan A Stein, Daniel Gipe, Jean Bergeron
exaly  

Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)

Circulation, 2019
Hidenori Arai, Takao Urabe, Ichiro Sakuma   +2 more
exaly  

Extended-Release Niacin or Ezetimibe and Carotid Intima–Media Thickness

New England Journal of Medicine, 2009
Neil J Weissman
exaly